| Leila Khorasani, MD | |
|
1100 9th Ave, Seattle, WA 98101-2756 | |
| (206) 223-7525 | |
| (206) 341-0443 |
| Full Name | Leila Khorasani |
|---|---|
| Gender | Female |
| Speciality | Neurological Surgery |
| Location | 1100 9th Ave, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861594574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | ML20007533 (Washington) | Secondary |
| 207T00000X | Neurological Surgery | MD60105159 (Washington) | Primary |
| Entity Name | The Association Of Chrmc And University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255449963 PECOS PAC ID: 9133032964 Enrollment ID: O20031107000585 |
News Archive
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region, according to data presented at the American Association for Cancer Research Frontiers in Basic Cancer Research Meeting.
TigerText, the #1 leader in secure, real-time messaging, has expanded its HIPAA compliant mobile messaging platform to a new healthcare segment, hospice providers, and today announced the addition of 7 new hospice organizations to its growing list of healthcare customers.
Vesico-ureteral reflux is present in a small minority of women with idiopathic high-pressure detrusor overactivity, suggests a study that identified this complication in 8% of women.
Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia. Apligraf is a living cell based product used by physicians to heal chronic wounds in patients in the U.S. and around the world.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome at Digestive Disease Week 2010 in New Orleans, Louisiana.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leila Khorasani, MD 1100 9th Ave, Seattle, WA 98101-2756 Ph: (206) 223-7525 | Leila Khorasani, MD 1100 9th Ave, Seattle, WA 98101-2756 Ph: (206) 223-7525 |
News Archive
Although a wide spectrum of human papillomavirus is seen across the population of India, HPV-16 and HPV-18 are the most common types and a vaccination targeting these types could eliminate 75 percent of the cervical cancers in the region, according to data presented at the American Association for Cancer Research Frontiers in Basic Cancer Research Meeting.
TigerText, the #1 leader in secure, real-time messaging, has expanded its HIPAA compliant mobile messaging platform to a new healthcare segment, hospice providers, and today announced the addition of 7 new hospice organizations to its growing list of healthcare customers.
Vesico-ureteral reflux is present in a small minority of women with idiopathic high-pressure detrusor overactivity, suggests a study that identified this complication in 8% of women.
Organogenesis, Inc. announced that its Apligraf® bilayered living cellular construct has been approved for the treatment of diabetic foot ulcers and other chronic wounds by the Saudi Food and Drug Authority (SFDA) of the Kingdom of Saudi Arabia. Apligraf is a living cell based product used by physicians to heal chronic wounds in patients in the U.S. and around the world.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, presented results from its positive Phase 2 clinical study with LX1031 in patients with non-constipating irritable bowel syndrome at Digestive Disease Week 2010 in New Orleans, Louisiana.
› Verified 6 days ago
George A Ojemann, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-5637 | |
Mr. Trent Lane Tredway, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 737 Olive Way Apt 2502, Seattle, WA 98101 Phone: 206-623-1334 Fax: 206-623-1677 | |
Daniel A Lazar, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1560 N 115th St, 209, Seattle, WA 98133 Phone: 206-368-1701 Fax: 206-363-0019 | |
Mohammed Basamh, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 550 17th Ave Ste 500, Seattle, WA 98122 Phone: 206-320-2451 | |
Dr. Christoph Paul Hofstetter, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Campus Box 356470, Room Rr734, Seattle, WA 98195 Phone: 507-202-9523 | |
David Keisho Su, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 900 Lenora St, 501, Seattle, WA 98121 Phone: 559-260-0047 | |
Syed Shabaz Azeem, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |